In lung cancer, multiple standard‐of‐care platinum‐based chemotherapies have been shown to increase PD‐L1 expression on both tumor cells and immune cells in patient biopsies, and both effects were associated with poorer overall response to therapy [67]. This evidence concerns the gene CD274 and lung cancer.